Tricuspid Valve Insufficiency
Conditions
Brief summary
The purpose of this study is to look at liver stiffness with a MRI sequence called Magnetic Resonance Elastography (MRE). The study will let the investigators know whether the subject's liver is normal or has increased stiffness. Increased liver stiffness often means there is chronic liver disease and fibrosis. Increased right heart pressure and congestive heart failure are considered risk factors for development of liver fibrosis. Liver fibrosis, if progressive, may lead to cirrhosis and its related complications. The increased liver stiffness may be due to a poorly functioning tricuspid valve. With this research, the investigators will be able to determine if the elevated stiffness of the liver returns to normal after the surgeon performs a repair or replacement of the tricuspid valve.
Interventions
DEVICEMRI
Subjects will receive an MRI sequence called Magnetic Resonance Elastography (MRE).
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Primary tricuspid valvular regurgitation (tricuspid valve disease not related to a left-sided cardiac abnormality) diagnosed by echocardiography * Evidence of passive hepatic congestion. Patients with severe tricuspid regurgitation diagnosed at echocardiography will constitute evidence of passive hepatic congestion. * Patient scheduled for surgical tricuspid valvular repair or replacement.
Exclusion criteria
* Contraindication for MRI (implantable devices such as cardiac pacemaker, anxiety, inability to lay supine, etc). * Additional conditions which may elevate their liver stiffness: hepatic fibrosis or cirrhosis, hepatic parenchymal disease (primary biliary cirrhosis, primary sclerosing cholangitis, etc), acute or chronic hepatitis (viral, substance or medication induced), disorders of hepatic vasculature, biliary obstruction or disease, primary or metastatic hepatic malignancy. * Cannot agree to return for a follow up visit to complete the postsurgical imaging.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in liver stiffness between preoperative and postoperative MR elastography (MRE) | baseline, approximately 6 months postoperatively | Increased liver stiffness often means there is chronic liver disease and fibrosis. |
| Change in tricuspid valve regurgitation measured by echocardiography | baseline, approximately 6 months postoperatively | Increased liver stiffness may be due to a poorly functioning tricuspid valve. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Subject Functional Capacity | baseline, approximately 6 months postoperatively | Subject Functional Capacity will be measured by the Self Assessment New York Heart Association (NYHA) Classification Scale. This questionnaire consists of 4 questions regarding the subject's ability to carry on physical activities. NYHA Class I = no symptoms in regular activity; NYHA Class II = Mild symptoms and slight limitation; NYHA Class III = noticeable limitations even during minimal activity; NYHA Class IV = severe limitations even while at rest. |
Outcome results
None listed